Korea S.E.
18:00:00 2024-05-13 EDT
5-day change
1st Jan Change
4,145
KRW
+1.72%
+4.28%
-4.38%
Carelabs Co.,Ltd authorizes a Buyback Plan.
The Board of Directors of Carelabs Co.,Ltd has authorized a buyback plan on October 14, 2021.
Humanscape, Inc. announced that it has received KRW 20 billion in funding from a group of investors
23-05-14
CI
Carelabs Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-12
CI
Wonik Holdings Co., Ltd completed the acquisition of 23.27% stake in Carelabs Co.,Ltd from Citylabs Co.,Ltd..
23-01-16
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on October 14, 2021.
22-04-14
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on October 14, 2021.
22-04-14
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on October 14, 2021.
22-04-14
CI
Carelabs Co.,Ltd's Equity Buyback announced on October 14, 2021, has expired with 14,221 shares, representing 0.08% for KRW 113.63 million.
22-04-13
CI
Carelabs Co.,Ltd authorizes a Buyback Plan.
21-10-13
CI
Carelabs Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
21-10-13
CI
Carelabs Co.,Ltd announced that it has received KRW 11 billion in funding from PSI International, Inc., NH Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm
21-03-14
CI
Carelabs Co.,Ltd announced that it has received KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm
21-01-06
CI
Carelabs Co.,Ltd announced that it expects to receive KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm
21-01-04
CI
Humanscape, Inc. announced that it has received KRW 13.1 billion in funding from Korea Investment Partners Co. Ltd., Green Cross Holdings Corporation, Nau IB Capital, Investment Arm, Carelabs Co.,Ltd, KB Securities Co., Ltd., Investment Arm
20-11-24
CI
Carelabs Co.,Ltd announced that it expects to receive KRW 20 billion in funding from PSI International, Inc., NH Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm
20-10-27
CI
Carelabs Co.,Ltd's Equity Buyback announced on March 16, 2020, has expired.
20-09-15
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on July 22, 2019.
20-07-27
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on July 22, 2019.
20-07-27
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on July 22, 2019.
20-07-27
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on July 22, 2019.
20-07-27
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on July 22, 2019.
20-07-27
CI
Carelabs Co., Ltd.'s Equity Buyback announced on July 22, 2019, has expired with 71,415 shares, representing 0.56% for KRW 990.32 million.
20-07-21
CI
Maple Investment Partners cancelled the acquisition of 33.5% stake in Carelabs Co.,Ltd from DAYLI BlockChain Co.,LTD. and Yello Mobile Inc.
20-06-29
CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on March 16, 2020.
20-06-17
CI
DAYLI BlockChain Co.,LTD. cancelled the acquisition of an unknown stake in Carelabs Co., Ltd. from Yello O2O Group Inc.
20-06-12
CI
Carelabs Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.
20-03-16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Carelabs Co.,Ltd is a Korea-based company mainly engaged in the development and sale of software. Along with subsidiaries, the Company operates its business through three segments. The Healthcare Digital Marketing segment is involved in marketing planning, production and agency business. The Healthcare Media Platform segment is involved in the provision of hospital pharmacy search services and community apps related to beauty care. The products are sold under the name of GOODOC and BABITALK. The Healthcare Solution segment provides customer relationship management (CRM) software, prescription security systems, and pharmacy billing programs. The Company distributes its products within the domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-4.38% 58.93M +12.48% 3,096B +12.99% 85.37B +7.63% 77.1B -13.71% 54.31B -22.72% 47.92B +25.28% 47.74B +21.30% 42.15B +68.57% 38.06B -8.87% 24.73B
Other Software
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
CARELABS CO.,LTD 
